Skip to content

Investor Relations / SEC Filings

SEC Filings

Filing date Form Filer Description View
D View HTML
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

View HTML
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

View HTML
SC 13G Southpoint Capital Advisors LP

A statement of beneficial ownership of common stock by certain persons

View HTML
SC 13G CLIMAX JOHN DR

A statement of beneficial ownership of common stock by certain persons

View HTML
SC 13G Sunninghill LTD

A statement of beneficial ownership of common stock by certain persons

View HTML
SC 13G CLIMAX JOHN DR

A statement of beneficial ownership of common stock by certain persons

View HTML
SC 13G Sunninghill LTD

A statement of beneficial ownership of common stock by certain persons

View HTML
SC 13G GELLER EHUD

A statement of beneficial ownership of common stock by certain persons

View HTML
SC 13G GREAT POINT PARTNERS LLC

A statement of beneficial ownership of common stock by certain persons

View HTML

Copyright Morningstar

copyright
© 2018, Amarin Corporation
Privacy policy  |  Disclaimer
Dublin Office
2 Pembroke House, Upper Pembroke
Street 28-32
Dublin 2, Ireland
US Investor Relations
Amarin Pharma Inc.
1430 Route 206
Bedminster, NJ 07921 USA
Telephone:
+1 908 719 1315
Fax:
+1 908 719 3012

Amarin Corporation